2015 Survey of European Biopharma CEOs and Board Members

Prior to our annual industry dinner in London, we surveyed 40 CEOs and board members of European biopharma firms to assess their views on capital availability, the viability of long-term independence for biopharma firms, and the challenges of finding transformational talent. The findings of the survey address the likelihood of a considerable increase in competition for talent, a potential division between talent haves and have nots, a reluctance to prepare for long-term independence and the need to place a greater emphasis on cultural fit when hiring.

Read coverage of the survey in Pharmaceutical Executive and European Pharmaceutical Review.